BioTime, Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference.EMERYVILLE, Calif. -- BioTime, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :BTIM) today announced that Michael D. West Dr. Michael D. West is an entrepreneurial scientist and visionary [1] [2] [3] [4] who has led progress in anti-aging and biotechnology. He is CEO of BioTime, Inc. , Ph.D., Chief Executive Officer, will present an update of the company's product development programs at 10:35 a.m. EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT on Tuesday, November 6, 2007, at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference, which is being held November 5-7, 2007 at the New York Palace
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of . The update will include information about BioTime's new initiative in regenerative medicine. The presentation will also include a review of the company's plasma expander products. The live audio webcast will be available at http://www.wsw.com/webcast/rrshq12/btim.ob or via BioTime's Investor Relations at www.biotimeinc.com. An archive of the presentation will be available for 90 days. About BioTime, Inc. BioTime, headquartered in Emeryville, California, develops blood plasma volume expanders, blood replacement solutions for hypothermic (low temperature) surgery, organ preservation solutions, and technology for use in surgery, emergency trauma treatment and other applications. BioTime's lead product Hextend is manufactured and distributed in the U.S. by Hospira, Inc. and in South Korea by CJ Corp. under exclusive licensing agreements. BioTime has recently entered the field of regenerative medicine where it plans to develop new medical and research products using embryonic stem cell Embryonic stem cells (ES cells) are stem cells derived from the inner cell mass of an early stage embryo known as a blastocyst. Human embryos reach the blastocyst stage 4-5 days post fertilization, at which time they consist of 50-150 cells. ES cells are pluripotent. technology. Information about BioTime can be found on the web at www.biotimeinc.com. Hextend([R])and PentaLyte([R]) are registered trademarks of BioTime, Inc. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion